Abstract
Hepatic cytochromes P-450 (CYP) are well characterized drug and xenobiotic metabolizing enzymes that are extensively regulated by genetic and environmental factors. Inflammatory mediators, including interleukins (ILs), interferons (IFNs), and tumor necrosis factor-α (TNF-α), have been shown to down-regulate several CYP isoforms; however, elucidation of the inflammatory mediators that are responsible for specific CYP down-regulation is difficult. The purpose of this experiment was to evaluate the role endogenous TNF-α plays in the regulation of liver CYP expression after endotoxin administration. Mice deficient in the p55 and p75 TNF receptors and wild-type mice were given Gram-negative bacterial lipopolysaccharide (LPS) and killed 24 h after administration. CYP analysis indicates that LPS decreases CYP1A, CYP2B, CYP3A, and CYP4A independently of TNF-α. CYP2D9 and CYP2E1 activities show differential responses to LPS between wild-type and TNF p55/p75 receptor knockout mice, indicating the down-regulation of CYP2D9 and CYP2E1 is differentially modulated by TNF-α expression. Furthermore, TNF-α appears to affect the constitutive expression of CYP2D9 and CYP2E1. To date, this is the first evidence suggesting that a proinflammatory cytokine is involved in the constitutive regulation of drug-metabolizing enzymes.
Footnotes
-
Send reprint requests to: Dr. Robert A. Blouin, College of Pharmacy, 907 Rose Street, University of Kentucky, Lexington, KY 40536-0082. E-mail: rbloul{at}pop.uky.edu.
-
↵1 This work was supported by National Institutes of Health Grants NS29001, AG14554, and NS35253 (M.P.M.) and Kentucky Spinal Cord Head Injury Research Trust Grant BB-9502-K (R.A.B.). G.W.W. was supported by Institutional NIEHS Training Grant ES07266 and a Quality Achievement Award by the University of Kentucky. S.M.P. was supported by the American Foundation for Pharmaceutical Education and the College of Pharmacy at the University of Kentucky.
- Abbreviations:
- CYP
- cytochrome P-450
- LPS
- lipopolysaccharide
- TNF-α
- tumor necrosis factor-α
- IL
- interleukin
- ELISA
- enzyme-linked immunosorbent assay
- OHT
- hydroxytestosterone
- LAH
- lauric acid ω-hydroxylase
- IFN
- interferon
- Received May 18, 1998.
- Accepted September 29, 1998.
- The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|